Publications by authors named "Jennifer D Prada-Vanegas"
Int J Dermatol
November 2024
Article Synopsis
- A study in Colombia aimed to estimate the frequency and costs of biologic treatments for psoriasis in 2019, focusing on data from the Ministry of Health.
- It found that out of 100,823 psoriasis patients, only 4.9% utilized biologic therapy, with the majority being male.
- The most commonly used biologics were ustekinumab, adalimumab, and secukinumab, costing an average of $12,880, $7,130, and $6,825 per patient per year, respectively.
